Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Elena Portacolone joins Ethics Talk to discuss her article, coauthored with Daisy Elise Feddoes: “Should Artificial Intelligence Play a Role in Cultivating Social Connections Among Older Adults?”
Perpetration-induced traumatic stress should be understood as present, not just posttraumatic, stress disorder because retraumatization is part of slaughterhouse workers’ jobs.
AMA J Ethics. 2023;25(4):E251-255. doi:
10.1001/amajethics.2023.251.
Clinical case and commentary on how physicians should respond when confronted by medication requests from parents of children with mood and concentration disorders.
Discussion of physician participation in interrogations during wartime based on the American Medical Association's Code of Medical Ethics, which prohibits physician monitoring of interrogations but allows patient care.